Entero Therapeutics Inc (ENTO) Live Share Price, Invest From India

Entero Therapeutics Inc Stock Performance

as on November 28, 2025 at 11:29 pm IST

Day's Low
Day's High
$2.84
Day's Price Range
$3.75
$2.98
4.70%
Downside
25.84%
Upside
52 Week's Low
52 Week's High
$0.97
52-Week Price Range
$5.84
$2.98
67.47%
Downside
95.97%
Upside

Entero Therapeutics Inc share price movements today

Previous Close: $2.84
Open: $3.25
Volume: 869.6K
Day's Low - High: $2.84 - $3.75
52 Week Low - High: $0.97 - $5.84

Entero Therapeutics Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Entero Therapeutics Inc Stock Fundamentals & Key Indicators

Check Entero Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

0.00%

Entero Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Entero Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Entero Therapeutics Inc	NA	$-	NA	NA	0.00%
Insmed Incorporated	BUY	$41.4B	388.11%	-16.34	-264.83%
Alnylam Pharmaceuticals, Inc.	BUY	$56.8B	229.4%	1433.4	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$113.3B	95.06%	31.11	31.35%
Regeneron Pharmaceuticals, Inc.	BUY	$74.5B	44.59%	16.85	32.13%

Entero Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	-	-	-	-	-
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-4	-3	-4	5	-8	-2	-12	-1	0	-1
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Entero Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-
Gross Profit	0	0	0	0	-
Operating Income	-	-	-	-	-
EBITDA	-	-	-	-	-
Interest Expense	-	-	-	-	-
Depreciation	-	-	-	-	-
Income Before Tax	-	-	-	-	-
Income Tax Expense	-	-	-	-	-
Net Income	-32	-58	-14	-15	-18
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%

Insights on Entero Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 176.4% return, outperforming this stock by 65.9%
NEGATIVE IMPACT
Price Dip
In the last 1 month, ENTO stock has moved down by -29.6%

About Entero Therapeutics Inc

Entero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal (GI) diseases. The Company is focused on developing the biologic Adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis (CF) and chronic pancreatitis (CP) patients with exocrine pancreatic insufficiency (EPI). Adrulipase is the active pharmaceutical ingredient (API) derived from Yarrowia lipolytica, an aerobic yeast naturally found in various foods such as cheese and olive oil that is widely used as a biocatalyst in several industrial processes. It is developing Adrulipase for two principal therapeutic indications: children and adults affected by CF, and adult patients with CP. Its subsidiary, Grid AI Corp., is an artificial intelligence (AI)-driven, grid-edge software and device orchestration platform.

Organisation	Entero Therapeutics Inc
E-voting on shares	Click here to vote

FAQs

What is Entero Therapeutics Inc share price today?

Entero Therapeutics Inc share price today is $2.98 as on November 28, 2025 at 11:29 pm IST. Entero Therapeutics Inc share today touched a day high of $3.75 and a low of $2.84.

What is the 52 week high and 52 week low for Entero Therapeutics Inc share?

Entero Therapeutics Inc share touched a 52 week high of $5.84 on October 15, 2025 and a 52 week low of $0.97 on April 30, 2025. Entero Therapeutics Inc stock price today i.e. November 28, 2025 at 11:29 pm IST is trending at $2.98,which is 48.97% down from its 52 week high and 207.44% up from its 52 week low.

How to invest in Entero Therapeutics Inc Stock (ENTO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Entero Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Entero Therapeutics Inc Shares that will get you 0.5034 shares as per Entero Therapeutics Inc share price of $2.98 per share as on November 28, 2025 at 11:29 pm IST.

What is the minimum amount required to buy Entero Therapeutics Inc Stock (ENTO) from India?

Indian investors can start investing in Entero Therapeutics Inc (ENTO) shares with as little as ₹89.928 or $1 (as of December 10, 2025 at 9:10 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹899.28 in Entero Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on December 10, 2025 at 9:10 pm IST). Based on Entero Therapeutics Inc share’s latest price of $2.98 as on November 28, 2025 at 11:29 pm IST, you will get 3.3557 shares of Entero Therapeutics Inc. Learn more about fractional shares .

Entero Therapeutics Inc Share Price